These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 526719

  • 1. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].
    Idle JR, Sloan TP, Smith RL, Wakile LA.
    Br J Pharmacol; 1979 Jul; 66(3):430P-431P. PubMed ID: 526719
    [No Abstract] [Full Text] [Related]

  • 2. Drug metabolism in uremia.
    Reidenberg MM.
    Clin Nephrol; 1975 Jul; 4(3):83-5. PubMed ID: 1102176
    [No Abstract] [Full Text] [Related]

  • 3. Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
    Eichelbaum M.
    Clin Pharmacokinet; 1982 Jul; 7(1):1-22. PubMed ID: 7042170
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M.
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F, von Bahr C.
    Drug Metab Dispos; 1973 Mar; 1(1):469-82. PubMed ID: 4149420
    [No Abstract] [Full Text] [Related]

  • 8. [Alcohol and drugs].
    De Baere H.
    Tijdschr Gastroenterol; 1976 Mar; 19(2):117-23. PubMed ID: 1013984
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW.
    N Z Med J; 1984 Aug 22; 97(762):567-9. PubMed ID: 6591031
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Individual variations in the oxidative metabolism of drugs. Significance of monogenic polymorphism].
    Brøsen K.
    Ugeskr Laeger; 1984 Mar 26; 146(13):955-9. PubMed ID: 6719598
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacogenetically hazardous drugs: a proposed new scoring method.
    Szórády I, Sánta A.
    Acta Physiol Hung; 1991 Mar 26; 77(3-4):305-18. PubMed ID: 1755332
    [Abstract] [Full Text] [Related]

  • 15. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D, Pessayre D, Benhamou JP.
    Gastroenterol Clin Biol; 1985 Mar 26; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract] [Full Text] [Related]

  • 16. Definition and implications of dose-dependent kinetics in clinical medicine.
    Holtzman JL.
    Drug Metab Rev; 1983 Mar 26; 14(6):1103-17. PubMed ID: 6426917
    [No Abstract] [Full Text] [Related]

  • 17. Genetic factors in drug therapy.
    Evans DA.
    Sci Basis Med Annu Rev; 1969 Mar 26; ():166-82. PubMed ID: 4918368
    [No Abstract] [Full Text] [Related]

  • 18. [Genetic causes for the variability of effects and side effects of drugs].
    Roots I.
    Internist (Berl); 1982 Nov 26; 23(11):601-9. PubMed ID: 6759450
    [No Abstract] [Full Text] [Related]

  • 19. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ.
    NIDA Res Monogr; 1991 Nov 26; 111():202-13. PubMed ID: 1775182
    [No Abstract] [Full Text] [Related]

  • 20. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J, Bergmann JF, Caulin C, Segrestaa JM.
    Therapie; 1990 Nov 26; 45(2):91-7. PubMed ID: 2191470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.